These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
468 related articles for article (PubMed ID: 31101119)
1. Nicotinamide N-methyltransferase enhances chemoresistance in breast cancer through SIRT1 protein stabilization. Wang Y; Zeng J; Wu W; Xie S; Yu H; Li G; Zhu T; Li F; Lu J; Wang GY; Xie X; Zhang J Breast Cancer Res; 2019 May; 21(1):64. PubMed ID: 31101119 [TBL] [Abstract][Full Text] [Related]
2. Nicotinamide N-methyltransferase overexpression may be associated with poor prognosis in ovarian cancer. Harmankaya İ; Akar S; Uğraş S; Güler AH; Ezveci H; Aydoğdu M; Çelik Ç J Obstet Gynaecol; 2021 Feb; 41(2):248-253. PubMed ID: 32285726 [TBL] [Abstract][Full Text] [Related]
3. Nicotinamide N-methyltransferase overexpression is associated with Akt phosphorylation and indicates worse prognosis in patients with nasopharyngeal carcinoma. Win KT; Lee SW; Huang HY; Lin LC; Lin CY; Hsing CH; Chen LT; Li CF Tumour Biol; 2013 Dec; 34(6):3923-31. PubMed ID: 23838801 [TBL] [Abstract][Full Text] [Related]
4. RNA-mediated gene silencing of nicotinamide N-methyltransferase is associated with decreased tumorigenicity in human oral carcinoma cells. Pozzi V; Sartini D; Morganti S; Giuliante R; Di Ruscio G; Santarelli A; Rocchetti R; Rubini C; Tomasetti M; Giannatempo G; Orlando F; Provinciali M; Lo Muzio L; Emanuelli M PLoS One; 2013; 8(8):e71272. PubMed ID: 23990942 [TBL] [Abstract][Full Text] [Related]
5. High stromal nicotinamide N-methyltransferase (NNMT) indicates poor prognosis in colorectal cancer. Song M; Li Y; Miao M; Zhang F; Yuan H; Cao F; Chang W; Shi H; Song C Cancer Med; 2020 Mar; 9(6):2030-2038. PubMed ID: 31989785 [TBL] [Abstract][Full Text] [Related]
6. Nicotinamide N-methyltransferase decreases 5-fluorouracil sensitivity in human esophageal squamous cell carcinoma through metabolic reprogramming and promoting the Warburg effect. Cui Y; Yang D; Wang W; Zhang L; Liu H; Ma S; Guo W; Yao M; Zhang K; Li W; Zhang Y; Guan F Mol Carcinog; 2020 Aug; 59(8):940-954. PubMed ID: 32367570 [TBL] [Abstract][Full Text] [Related]
7. Knockdown of nicotinamide N-methyltransferase suppresses proliferation, migration, and chemoresistance of Merkel cell carcinoma cells in vitro. Pozzi V; Molinelli E; Campagna R; Serritelli EN; Cecati M; De Simoni E; Sartini D; Goteri G; Martin NI; van Haren MJ; Salvolini E; Simonetti O; Offidani A; Emanuelli M Hum Cell; 2024 May; 37(3):729-738. PubMed ID: 38504052 [TBL] [Abstract][Full Text] [Related]
8. Qian Yang Yu Yin Granule protects against hypertension-induced renal injury by epigenetic mechanism linked to Nicotinamide N-Methyltransferase (NNMT) expression. Zhang SF; Mao XJ; Jiang WM; Fang ZY J Ethnopharmacol; 2020 Jun; 255():112738. PubMed ID: 32147479 [TBL] [Abstract][Full Text] [Related]
9. Role of nicotinamide N-methyltransferase in non-small cell lung cancer: in vitro effect of shRNA-mediated gene silencing on tumourigenicity. Sartini D; Seta R; Pozzi V; Morganti S; Rubini C; Zizzi A; Tomasetti M; Santarelli L; Emanuelli M Biol Chem; 2015 Mar; 396(3):225-34. PubMed ID: 25204218 [TBL] [Abstract][Full Text] [Related]
10. Targeting nicotinamide N-methyltransferase decreased aggressiveness of osteosarcoma cells. Serritelli EN; Sartini D; Campagna R; Pozzi V; Martin NI; van Haren MJ; Salvolini E; Cecati M; Rubini C; Emanuelli M Eur J Clin Invest; 2024 Jun; 54(6):e14185. PubMed ID: 38426563 [TBL] [Abstract][Full Text] [Related]
11. Down-regulation of nicotinamide N-methyltransferase induces apoptosis in human breast cancer cells via the mitochondria-mediated pathway. Zhang J; Wang Y; Li G; Yu H; Xie X PLoS One; 2014; 9(2):e89202. PubMed ID: 24558488 [TBL] [Abstract][Full Text] [Related]
12. Inhibiting proliferation in KB cancer cells by RNA interference-mediated knockdown of nicotinamide N-methyltransferase expression. Pozzi V; Mazzotta M; Lo Muzio L; Sartini D; Santarelli A; Renzi E; Rocchetti R; Tomasetti M; Ciavarella D; Emanuelli M Int J Immunopathol Pharmacol; 2011; 24(1):69-77. PubMed ID: 21496389 [TBL] [Abstract][Full Text] [Related]
13. SIRT1 promotes proliferation, migration, and invasion of breast cancer cell line MCF-7 by upregulating DNA polymerase delta1 (POLD1). Xu Y; Qin Q; Chen R; Wei C; Mo Q Biochem Biophys Res Commun; 2018 Jul; 502(3):351-357. PubMed ID: 29807012 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of nicotinamide N-methyltransferase in HSC-2 OSCC cell line: effect on apoptosis and cell proliferation. Seta R; Mascitti M; Campagna R; Sartini D; Fumarola S; Santarelli A; Giuliani M; Cecati M; Muzio LL; Emanuelli M Clin Oral Investig; 2019 Feb; 23(2):829-838. PubMed ID: 29882109 [TBL] [Abstract][Full Text] [Related]
15. Nicotinamide N-methyltransferase enhances the capacity of tumorigenesis associated with the promotion of cell cycle progression in human colorectal cancer cells. Xie X; Yu H; Wang Y; Zhou Y; Li G; Ruan Z; Li F; Wang X; Liu H; Zhang J Arch Biochem Biophys; 2014 Dec; 564():52-66. PubMed ID: 25201588 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of sirtuin 1 deacetylase by miR-211-5p provides a mechanism for the induction of cell death in breast cancer cells. Yarahmadi S; Abdolvahabi Z; Hesari Z; Tavakoli-Yaraki M; Yousefi Z; Seiri P; Hosseinkhani S; Nourbakhsh M Gene; 2019 Aug; 711():143939. PubMed ID: 31220581 [TBL] [Abstract][Full Text] [Related]
17. Expression of nicotinamide N-methyltransferase in hepatocellular carcinoma is associated with poor prognosis. Kim J; Hong SJ; Lim EK; Yu YS; Kim SW; Roh JH; Do IG; Joh JW; Kim DS J Exp Clin Cancer Res; 2009 Feb; 28(1):20. PubMed ID: 19216803 [TBL] [Abstract][Full Text] [Related]
18. SIRT1 promotes tumorigenesis and resistance to chemotherapy in hepatocellular carcinoma and its expression predicts poor prognosis. Chen HC; Jeng YM; Yuan RH; Hsu HC; Chen YL Ann Surg Oncol; 2012 Jun; 19(6):2011-9. PubMed ID: 22146883 [TBL] [Abstract][Full Text] [Related]